Harvard Bioscience (HBIO) Non Operating Investment Income (2023 - 2024)
Harvard Bioscience's (HBIO) quarterly Non Operating Investment Income came in at -$281000.0 in Q2 2024, up 82.23% year-on-year from -$154203.7 in Q3 2023, and up 78.58% on a QoQ basis from -$1.3 million in Q1 2024.
Harvard Bioscience (HBIO) Non Operating Investment Income (2023 - 2024) Analysis & Trends
Harvard Bioscience (HBIO) has 2 years of Non Operating Investment Income data on file, last reported at -$281000.0 in Q2 2024.
- On a quarterly basis, Non Operating Investment Income rose 82.23% year-over-year to -$281000.0 in Q2 2024; TTM through Mar 2025 was -$281000.0, a 85.55% increase from a year earlier, with the FY2024 full-year figure at -$1.6 million, down 152.06% from the prior year.
- Non Operating Investment Income for Q2 2024 stood at -$281000.0, up from -$1.3 million in the prior quarter.
- Over the last five years, Non Operating Investment Income for HBIO reached as high as $1.2 million in Q3 2023 and fell as low as -$1.6 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -10.13 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | - |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -281,000.00 |
| Jun 30, 2024 | -281,000.00 |
| Mar 31, 2024 | -1.31 Mn |
| Mar 31, 2024 | -1.31 Mn |
| Dec 31, 2023 | -259,000.00 |
| Dec 31, 2023 | -259,000.00 |
| Sep 30, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | -1.58 Mn |
| Jun 30, 2023 | -1.58 Mn |